Elisabeth Shim is a Dermatology physician affiliated with University of Southern California. OpenAlex indexes 15 publications with 856 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1301 20th St
Suite 570
Santa Monica, CA 90404
Telephone
310-315-0171Registry record last updated 8 Jul 2007.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Organogenesis Inc.Program year20251 payment
- Galderma Laboratories, L.P.Program year20221 payment
- Bioventus LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
50.8%Azole Antifungal19.3%Ketoconazole100%Part D≥127 patientsFirst-generation cephalosporins16.6%Cephalexin100%Part D≥116 patients+ 5 more classes in this area
Respiratory
12.9%Corticosteroid8.9%Mometasone Furoate100%Part D≥61 patientsRNA Synthetase Inhibitor Antibacterial4%Mupirocin100%Part D≥24 patientsDermatology
10.1%Corticosteroid4.9%Triamcinolone Acetonide66%Triamcinolone acetonide34%Part D + Part B≥25 patientsPolyene Antifungal3.5%Nystatin100%Part D≥30 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Treatment of fibroelastolytic papulosis with fractionated carbon dioxide laser
Journal of Cosmetic and Laser Therapy
2014 - Use of eye shields and eye lubricants among oculoplastic and Mohs surgeons: a survey.
PubMed
2009
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”